Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

BMI is "not a useless metric," but "many medical professionals believe that adiposity, or the accumulation of body fat, is a ...

A healthier diet and reduced waist-to-hip ratio during midlife are linked to improved brain and cognitive health in later years, longitudinal findings from the Whitehall II cohort study show.

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Experts advocate maintaining BMI 25 standard for obesity at Korean health conference Health experts call for adherence to BMI ...

The Dow, S&P 500, and Nasdaq fell Thursday as the stock market digested the latest economic data and Trump's response to Canada and EU tariffs. The S&P 500 closed in correction territory.

A new screening intervention in the primary care setting can improve the identification and management of obesity risk in pediatric patients, according to a poster presented at the National ...

Research published in Nature determined why obese individuals who lose weight tend to regain the weight over time. Here's how ...

“By identifying individuals in a preclinical obesity phase, where they are not yet classified as obese but are showing signs of metabolic dysregulation, there is an opportunity for earlier ...

Recent discussions have emerged challenging the traditional reliance on BMI for diagnosing obesity, advocating for a more precise approach that considers individual health factors.

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.